Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Total Equity

Gilead Sciences Inc Total Equity Chart (GILD)

Gilead Sciences Inc annual/quarterly Total Equity from 2010 to 2020.
  • Gilead Sciences Inc Total Equity for the quarter ending September 09, 2020 was $17,471m a -29.64% decrease of -5,179m year over year
  • Gilead Sciences Inc Total Equity for the last 12 months ending September 09, 2020 was $17,471m a -29.64% decrease of -5,179m year over year
  • Gilead Sciences Inc Annual Total Equity for 2019 was $22,650m a 4.93% increase of 1,116m from 2018
  • Gilead Sciences Inc Annual Total Equity for 2018 was $21,534m a 4.80% increase of 1,033m from 2017
  • Gilead Sciences Inc Annual Total Equity for 2017 was $20,501m a 5.55% increase of 1,138m from 2016
Other Balance Sheet Metrics:
  • Gilead Sciences Inc Total Assets for the quarter ending December 12, 2018 was $63,675m a -2.68% decrease of -1,706m year over year
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
View Chart On Koyfin

Quarterly GILD Total Equity Data

09/2020$17,471m
06/2020$18,142m
03/2020$22,179m
12/2019$22,650m
09/2019$20,736m
06/2019$22,751m
03/2019$22,091m
12/2018$21,534m
09/2018$23,007m
06/2018$21,734m

Annual GILD Total Equity Data

2019$22,650m
2018$21,534m
2017$20,501m
2016$19,363m
2015$19,115m
2014$15,834m
2013$11,809m
2012$9,551m
2011$6,867m
2010$6,122m